Quality of Life Surveys

OTHER5 trials

Sponsors

Central Hospital, Nancy, France, The Guthrie Clinic, Manchester University NHS Foundation Trust, Abramson Cancer Center at Penn Medicine, University of California, San Francisco

Conditions

Ascites HepaticAscites, MalignantBreast CancerCAR T-Cell TherapyColorectal CancerHematological CancerLung CancerMultiple Myeloma

Unknown Phase

Cost-Utility Analysis Hospital Versus Home in Multiple Myeloma

CompletedNCT03493737

Central Hospital, Nancy, FranceMultiple Myeloma

Start: 2018-04-10End: 2020-02-15Updated: 2020-08-17

Survey Study: Financial Impact of Breast Cancer Treatment

CompletedNCT03615573

The Guthrie ClinicBreast Cancer

Start: 2018-09-04End: 2024-02-10Updated: 2024-11-07

Enhanced Monitoring for Better Recovery and Cancer Experience in Greater Manchester

Manchester University NHS Foundation TrustCAR T-Cell Therapy, Colorectal Cancer, Hematological Cancer +1

Start: 2021-12-01End: 2023-12-31Target: 80Updated: 2023-05-03

QOL and Sarcopenia in Patients With Ascites

RecruitingNCT05726747

Abramson Cancer Center at Penn MedicineAscites Hepatic, Ascites, Malignant

Start: 2023-05-23End: 2026-10-31Target: 70Updated: 2025-08-29

Predicting Cognitive Decline From Androgen Deprivation Therapy

Active, not recruitingNCT05820932

University of California, San FranciscoProstate Cancer

Start: 2023-05-22End: 2026-02-28Updated: 2026-02-24

Related Papers

WTP5.6 Enhanced Monitoring for Better Recovery and Cancer Experience in Greater Manchester (EMBRaCE-GM): A Qualitative Study of Clinician Experiences on Deploying and Supporting Consumer Wearable Devices

British journal of surgery2023-08-21